Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus

Advances in Chronic Kidney Disease

Volumn 21, Issue 3, 2014, Pages 267-272

  Marshall, Sally M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CKD in diabetes; Diabetic nephropathy; Microalbuminuria KDIGO CKD albuminuria A2; Natural history of diabetic nephropathy; Proteinuria KDIGO CKD albuminuria A3

Indexed keywords

GLUCOSE;

AGING; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HISTOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS;

EID: 84899544397     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.03.007     Document Type: Review

References (43)

1. Stevens P.E., Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013, 158(11):825-830. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members.
2. Magee G.M., Bilous R.W., Cardwell C.R., Hunter S.J., Kee F., Fogarty D.G. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009, 52(4):691-697.
3. Jerums G., Premaratne E., Panagiotopoulos S., MacIsaac R.J. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010, 53(10):2093-2104.
4. Ponchiardi C., Mauer M., Najafian B. Temporal profile of diabetic nephropathy pathologic changes. Curr Diab Rep 2013, 13(4):592-599.
5. Suh J.H., Miner J.H. The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol 2013, 9(8):470-477.
6. Marshall S.M., Flyvbjerg A. Prevention and early detection of vascular complications in diabetes. BMJ 2006, 333(7566):475-480.
7. Kramer C.K., Retnakaran R. Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial. Diabetic Med 2013, 30(11):1333-1341.
8. The Microalbuminuria Collaborative Study Group Risk factors for development of microalbuminuria in insulin-dependent diabetic patients: a cohort study. BMJ 1993, 306(6867):1235-1239.
9. Amin A.P., Whaley-Connell A.T., Li S., Chen S.C., McCullough P.A., Kosiborod M.N. The synergistic relationship between estimated GFR and microalbuminuria in predicting long term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013, 61(4 suppl 2):S12-S23. KEEP Investigators.
10. Adler A.L., Stevens R.J., Manley S.E., Bilous R.W., Cull C.A., Holman R.R. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003, 63(1):225-232. UKPDS Group.
11. Hasslacher C., Ritz E., Wahl P., Michael C. Similar risks of nephropathy in patients with type 1 or type 2 diabetes mellitus. Nephrol Dial Transplant 1989, 4(10):859-863.
12. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989, 320(18):1161-1165.
13. Thorn L.M., Forsblom C., Fagerudd J., Pettersson-Fernholm K., Kilpikari R., Groop P.H. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care 2007, 30(5):1162-1167. FinnDiane Study Group.
14. Feldt-Rasmussen B., Mathiesen E.R. Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabetic Nephropathy 1984, 3(1):101-103.
15. Molitch M.E., Steffes M., Sun W., et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010, 33(7):1536-1543. Epidemiology of Diabetes Interventions and Complications Study Group.
16. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., Krolewski A.S. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003, 348(23):2285-2293.
17. Yuyun M.F., Dineen S.F., Edwards O.M., Wood E., Wareham N.J. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabetic Med 2003, 20(4):277-282.
18. Spoelstra-de Man A.M., Brouwer C.B., Stehouwer C.D., Smulders Y.M. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 2001, 24(12):2097-2101.
19. Schultz C.J., Neil H.A., Dalton R.N., Dunger D.B. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care 2000, 23(12):1811-1815. Oxford Regional Prospective Study Group.
20. Mathiesen E.R., Oxenboll B., Johansen K., Svendsen P.A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984, 26(6):406-410.
21. Mathiesen E.R., Feldt-Rasmussen B., Hommel E., Deckert T., Parving H.H. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study. Diabetes Care 1997, 20(3):286-289.
22. de Boer I.H., Rue T.C., Cleary P.A., et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011, 171(5):412-420.
23. Rossing K., Christensen P.K., Hovind P., Parving H.H. Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 2005, 48(11):2241-2247.
24. Hovind P., Rossing P., Tarnow L., Smidt U.M., Parving H.H. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int 2001, 60(1):277-283.
25. Marshall S.M. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980's?. Diabetologia 2012, 55(9):2301-2306.
26. Andersen A.R., Sandahl Christiansen J., Andersen L.K., Kreiner S., Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983, 25(6):496-501.
27. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group Modern-day clinical course of type 1 diabetes mellitus after 30 years. Arch Intern Med 2009, 169(14):1307-1316.
28. Pambianco G., Costacou T., Ellis D., Becker D.J., Klein R., Orchard T. The 30-year natural history of type 1 diabetes complications. Diabetes 2006, 55(5):1463-1469.
29. Hovind P., Tarnow L., Rossing K., et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003, 26(4):1258-1264.
30. Nordwall M., Bojestig M., Arnqvist H.J., Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes-the Linkoping Diabetes Complications Study. Diabetologia 2004, 47(7):1266-1272. Linkoping Diabetes Complications Study.
31. Finne P., Reunanen A., Stenman S., Groop P.H., Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. J Am Med Assoc 2005, 294(14):1782-1787.
32. Mollsten A., Svensson M., Waernbaum I., et al. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes. Diabetes 2010, 59:1803-1808.
33. Pinhas-Hamiel O., Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007, 369(9575):1823-1831.
34. Scott A., Toomath R., Bouchier D., et al. First national audit of outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders. N Z Med J 2006, 119(1235):U2015.
35. Eppens M.C., Craig M.E., Jones T.W., Silink M., Ong S., Ping Y.J. International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin 2006, 22(5):1013-1020.
36. Maahs D.M., Snively B.M., Bell R.A., et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes. Diabetes Care 2007, 30(10):2593-2598.
37. Dart A.B., Selleres E.A., Martens P.J., Rigatio C., Brownell M.D., Dean H.J. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 2012, 35(6):1265-1271.
38. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., Holman R.R. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes study 74. Diabetes 2006, 55(6):1832-1839. UKPDS Study Group.
39. Kramer H.J., Nguyen Q.D., Curham G., Hsu C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. J Am Med Assoc 2003, 289(24):3273-3277.
40. MacIsaac R.J., Tsalamandris C., Panagiotopoulos S., Smith T.J., McNeil K.J., Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004, 27(1):195-200.
41. Costacou T., Ellis P., Fried L., Orchard T.J. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 2007, 50(5):721-732.
42. Fioretto P., Mauer M., Brocco E., et al. Patterns of renal injury in NIDDM patients with microalbuminruia. Diabetologia 1996, 39(12):1569-1576.
43. Ekinci E.I., Jerums G., Skene A., et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 2013, 36(11):3620-3626.